Keywords: Cardiac Rehabilitation, Secondary Prevention, Cardiorespiratory Fitness, Health Span, Biological Aging, Psychosocial Well-Being
Introduction
The Global Burden of Cardiovascular Disease
Cardiovascular disease (CVD) remains the foremost cause of premature death and disability worldwide, responsible for an estimated 17.9 million deaths annually, approximately 32% of all global mortality. The spectrum of CVD encompasses coronary artery disease (CAD), heart failure (HF), peripheral artery disease (PAD), stroke, and structural cardiac conditions, each carrying substantial individual and societal burdens. In high-income countries, advances in acute coronary intervention, pharmacotherapy, and device-based therapies have dramatically reduced short-term case fatality rates following events such as myocardial infarction (MI) and cardiac surgery. The consequence, however, is an expanding population of cardiac survivors who require comprehensive management to prevent recurrence, manage residual risk, and restore functional capacity [1].
The risk factor burden contributing to CVD continues to escalate globally. Obesity prevalence has tripled since 1975, with more than 650 million adults classified as obese by the World Health Organization. Type 2 diabetes mellitus (T2DM) affects approximately 537 million adults worldwide, a figure projected to reach 783 million by 2045. Hypertension, physical inactivity, dyslipidaemia, and tobacco use compound the risk landscape, creating a syndemic of interacting, mutually reinforcing risk factors that accelerate both atherosclerotic progression and biological aging. Addressing this syndemic requires interventions that are comprehensive, personalised, and sustained, qualities that define well-delivered cardiac rehabilitation.
Historical Development of Cardiac Rehabilitation
The concept of CR underwent a fundamental transformation during the mid-twentieth century. Prior to the 1950s, the dominant medical paradigm following MI was prolonged bed rest, sometimes extending six to eight weeks based on the belief that physical exertion posed unacceptable risks to the healing myocardium. The landmark work of Levine and Lown in 1952, introducing “armchair treatment” with early mobilisation, and the subsequent pioneering studies of Hellerstein and Ford in the 1950s and 1960s, demonstrating the safety and feasibility of structured exercise post-MI, challenged this orthodoxy fundamentally [7].
By the 1970s and 1980s, formal CR programmes emerged in North America and Europe, initially focused primarily on supervised exercise. The World Health Organization’s definition in 1964, recognising CR as addressing physical, mental, and social functioning, presaged the multidisciplinary model that defines contemporary practice. The pivotal meta-analyses of the 1980s and 1990s, culminating in the Cochrane reviews of the 2000s and 2010s, established the evidence base for mortality reduction that underpins current guideline recommendations from the American Heart Association (AHA), the European Society of Cardiology (ESC), and the National Institute for Health and Care Excellence (NICE) [2,3,7,12].
Cardiac Rehabilitation and Longevity Science
Longevity medicine, the clinical discipline concerned with extending not merely lifespan but health span (the period of life characterised by good health, functional independence, and quality of life) has emerged as one of the most rapidly growing fields in medicine. It draws on molecular gerontology, exercise physiology, nutritional science, endocrinology, and behavioural medicine to identify modifiable determinants of biological aging and develop targeted interventions. Central to this framework are concepts such as cardiorespiratory fitness, metabolic homeostasis, systemic inflammation, body composition, psychosocial resilience, and the integrity of biological processes including mitochondrial function, telomere maintenance, and epigenetic regulation.
Remarkably, cardiac rehabilitation directly addresses every one of these domains. Its core components like structured exercise training, metabolic risk factor management, psychosocial intervention, and lifestyle behavioural support are precisely the interventions that longevity science identifies as the most powerful modifiers of biological age and all-cause mortality. This alignment is not coincidental; it reflects the fundamental convergence of cardiovascular pathophysiology and aging biology. CVD and accelerated aging share common mechanisms, including oxidative stress, chronic low-grade inflammation, endothelial dysfunction, mitochondrial deterioration, and autonomic dysregulation, and CR is uniquely positioned to interrupt these shared pathways simultaneously.
Despite this compelling theoretical framework and extensive empirical evidence, CR is profoundly underutilised. Globally, fewer than 30% of eligible patients access CR following a cardiac event, with rates as low as 5-10% in many low- and middle-income countries. The reasons for this disparity are multifactorial, spanning physician referral patterns, patient awareness, programme availability, socioeconomic barriers, and systemic healthcare resource allocation. Critically, this underutilisation represents not only a missed opportunity for cardiovascular secondary prevention, but a failure to deploy one of the most potent longevity interventions available in clinical practice [4].
Purpose and Scope of This Review
This narrative review aims to provide a comprehensive, evidence-based synthesis of cardiac rehabilitation as a longevity intervention. We examine its structure, phases, and core components; explore its mechanisms and outcomes across four central longevity domains which are exercise physiology, metabolic health, secondary prevention, and psychosocial well-being; discuss considerations for special populations; connect CR evidence to the emerging science of biological aging; analyse barriers to access and effective strategies to overcome them; and offer a forward-looking perspective on the future of CR in an era of digital health, artificial intelligence, and precision medicine.
Cardiac Rehabilitation: Structure, Phases, and Core Components
Definition and Scope
Cardiac rehabilitation is defined by the World Health Organization as “the sum of activities required to ensure cardiac patients the best possible physical, mental, and social conditions so that they may, by their own efforts, resume and maintain as normal a place as possible in the community”. In contemporary clinical practice, this definition has been operationalised into a structured, multidisciplinary programme that extends across the continuum from acute hospitalisation through long-term maintenance. CR is indicated for patients with established CVD including CAD (post-MI, post-percutaneous coronary intervention, post-coronary artery bypass grafting), chronic heart failure (HFrEF and HFpEF), peripheral artery disease, and increasingly, those undergoing transcatheter aortic valve replacement (TAVR) and other structural heart interventions [7].
Phase of Cardiac Rehabilitation
Phase I: Inpatient Rehabilitation
Phase I commences during the acute hospital admission, ideally within 24-48 hours of a cardiac event or procedure, once the patient is haemodynamically stable. The primary goals of Phase I are early mobilisation to prevent deconditioning and the sequelae of bed rest (including muscle atrophy, orthostatic hypotension, thromboembolic risk, and impaired pulmonary function); risk stratification; patient and family education about the cardiac condition, medications, warning signs, and the value of continued rehabilitation; and psychosocial assessment. Exercise in Phase I is characteristically low-intensity, supervised ambulation, gentle range-of-motion activities, and stair climbing and is titrated to patient symptoms, heart rate, and monitored haemodynamic response. A referral and discharge plan for Phase II CR is a critical deliverable of Phase I, and automatic referral systems (rather than relying on physician initiation) have been shown to significantly improve subsequent Phase II enrolment rates [4].
Phase II: Outpatient Supervised Rehabilitation
Phase II is the cornerstone of CR and forms the basis of the evidence base supporting CR outcomes. Typically beginning one to three weeks after hospital discharge, Phase II involves structured, professionally supervised sessions, generally two to five times per week for a minimum of 36 sessions (the standard covered by most healthcare systems) over 6-12 weeks. Sessions typically last 60-90 minutes and include a warm-up phase (10 minutes), the aerobic exercise component (20-40 minutes at target intensity), resistance training (15-20 minutes), and a cool-down phase (10 minutes). Continuous electrocardiographic monitoring, blood pressure assessment, and symptom surveillance are standard during Phase II, enabling safe progression and early detection of exercise-induced complications.
Beyond the exercise component, Phase II encompasses comprehensive risk factor management including lipid-lowering therapy optimisation, antihypertensive titration, diabetic medication review, smoking cessation support, and dietary assessment and counselling. Psychosocial assessment using validated instruments (e.g., the Hospital Anxiety and Depression Scale, PHQ-9, or GAD-7) identifies patients requiring psychological intervention. Individual and group educational sessions address topics including cardiac anatomy and physiology, understanding medications, cardioprotective diet, stress management, sleep optimisation, return to physical activity and sexual activity, and long-term lifestyle maintenance. These elements combine to create a therapeutic environment that addresses not only the physiological but the cognitive, emotional, and behavioural dimensions of cardiac recovery.
Long-Term Maintenance
Phase III represents the transition from supervised rehabilitation to independently sustained lifestyle change, typically occurring after completion of Phase II. It may be delivered in community-based fitness facilities, peer support groups, home-based settings, or increasingly via digital platforms. The central challenge of Phase III is maintaining the physiological and behavioural gains achieved during Phase II over months, years, and ultimately decades, the timescale most relevant to longevity outcomes. Studies consistently demonstrate that CR benefits, including CRF gains and cardiovascular risk factor improvements, attenuate within 6-12 months of programme cessation in patients who return to sedentary behaviour, underscoring the imperative of sustained physical activity [14].
The Multidisciplinary CR Team
Effective CR requires a coordinated multidisciplinary team whose composition reflects the programme’s comprehensive scope. Core team members typically include exercise physiologists or physiotherapists (responsible for exercise prescription and progression), cardiologists or cardiac nurses (providing medical oversight and risk stratification), dietitians or nutritionists (conducting dietary assessment and providing individualised nutritional counselling), clinical psychologists or social workers (delivering psychosocial assessment and intervention), and pharmacists (performing medication reconciliation and adherence support). Additional specialist input may include occupational therapists (supporting return to work), sleep medicine specialists, and increasingly, health coaches and digital health coordinators. The multidisciplinary model is not merely additive, it is synergistic, with each team member addressing domains of health that, individually treated, would yield smaller benefits than when integrated.
Core Components: The AHA/AACVPR Framework
The American Heart Association and American Association of Cardiovascular and Pulmonary Rehabilitation define eight core components of CR: (1) baseline patient assessment including medical history, risk stratification, and fitness testing; (2) nutritional counselling with emphasis on cardioprotective dietary patterns (Mediterranean, DASH); (3) risk factor management targeting lipids, blood pressure, weight, diabetes, and tobacco use; (4) psychosocial management addressing depression, anxiety, stress, and social support; (5) physical activity counselling to promote daily activity beyond structured exercise sessions; (6) exercise training with individualised aerobic and resistance exercise prescription; (7) education on return to occupational and social activities; and (8) outcomes assessment using validated, standardised measures. Each component is individually evidence-based and mutually reinforcing, and programmes delivering all eight components consistently demonstrate superior outcomes compared to those focused on exercise training alone [2].
Exercise Training: The Cornerstone of Cardiac Rehabilitation
Principles of Exercise in CR
Exercise prescription in CR follows the FITT-VP principle, Frequency, Intensity, Time, Type, Volume, and Progression, individualised to the patient’s risk stratification, baseline fitness, comorbidities, and treatment goals. Risk stratification, typically performed using criteria from the AHA or the AACVPR, classifies patients as low, moderate, or high risk, determining the degree of supervision, monitoring, and intensity progression appropriate for each individual. Cardiopulmonary exercise testing (CPET), measuring peak VO2 and ventilatory anaerobic threshold (VAT), provides the most precise physiological basis for exercise prescription and is the gold standard for both baseline assessment and outcome evaluation in CR [10].
Aerobic Training: Evidence, Protocols, and Physiological Adaptations
Moderate-intensity continuous training (MICT), sustained aerobic exercise at 50-80% of heart rate reserve or VO2peak for 20-60 minutes per session has been the traditional CR exercise modality and remains the most extensively studied. Its physiological adaptations include increased maximal cardiac output (through both increased stroke volume and improved heart rate response), enhanced oxygen delivery via angiogenesis and increased capillary density in skeletal muscle, augmented mitochondrial density and oxidative enzymatic activity, improved endothelial function with enhanced nitric oxide bioavailability, and reduced sympathetic nervous system activity. These adaptations collectively translate to improvements in VO2max of 10-20% over a standard Phase II programme, with greater absolute gains in patients with lower baseline fitness — precisely the patients at highest mortality risk [5,10,11].
High-intensity interval training (HIIT), characterised by alternating bouts of high-intensity aerobic effort (85-95% of peak heart rate) with active recovery periods, has emerged as a powerful and increasingly well-validated alternative to MICT in selected cardiac populations. A systematic review and meta-analysis by Pattyn et al. (2014) demonstrated that HIIT produced superior VO2max improvements compared to MICT (mean difference +1.78 mL/kg/min) without a significantly greater incidence of adverse events, including in patients with CAD and heart failure. HIIT protocols employed in CR vary in structure; common formats include the Norwegian 4×4 protocol (four four-minute intervals at 85-95% HRmax interspersed with three three-minute active recovery periods) and shorter 1-minute or 30-second interval formats. The superior CRF gains of HIIT reflect greater cardiovascular stress per unit of exercise time, driving stronger adaptations in central (cardiac) and peripheral (skeletal muscle) oxygen transport systems [8].
Resistance Training: Rationale and Evidence
Resistance training (RT) is a complementary and increasingly integral component of CR exercise programming. Its rationale stems from the recognition that CVD patients, particularly older adults and those with heart failure, frequently exhibit significant skeletal muscle wasting, weakness, and impaired functional capacity that aerobic training alone does not fully address. RT stimulates skeletal muscle protein synthesis, increases muscle cross-sectional area, improves neuromuscular coordination, and enhances muscular endurance , adaptations that improve functional performance in activities of daily living (ADLs), reduce fall risk, and combat sarcopenia [9].
The haemodynamic safety of RT in cardiac populations has been established in multiple RCTs. When performed at moderate intensity (50-70% of one-repetition maximum) with appropriate rest intervals, RT does not produce clinically concerning pressure overload responses in appropriately risk-stratified patients. Combined aerobic and resistance training programmes produce superior improvements in lean muscle mass, body composition, insulin sensitivity, and functional capacity compared to aerobic training alone, while equivalent or superior gains in VO2max, supporting the inclusion of RT as a standard component of CR exercise prescription [9,22].
Cardiorespiratory Fitness as the Most Powerful Longevity Biomarker
Among all measurable physiological variables, cardiorespiratory fitness, quantified as peak oxygen uptake (VO2peak) or VO2max has consistently emerged as the single strongest independent predictor of all-cause and cardiovascular mortality across the full spectrum of health and disease. The association between CRF and mortality is inverse, continuous, and graded: each 1 MET (3.5 mL O2/kg/min) increment in CRF is associated with an approximately 13% reduction in all-cause mortality and 15% reduction in cardiovascular mortality, after adjusting for traditional risk factors including age, sex, smoking, hypertension, dyslipidaemia, and diabetes [5,10].
Critically, data from Myers et al. (2002), published in the New England Journal of Medicine, demonstrated that exercise capacity was a stronger predictor of mortality than any other established cardiovascular risk factor in men referred for exercise testing. The Cooper Clinic cohort, the Veterans Exercise Testing Study, and Nordic cohort data have replicated this finding across diverse populations and geographies. The clinical implication is profound: CR-induced improvements in VO2max of 10-25%, which shift patients from lower to higher fitness quintiles, translate directly to measurable reductions in long-term mortality risk, effects that persist for years beyond programme completion in patients who maintain active lifestyles [10,11,25].
Autonomic Nervous System Adaptations
CVD is characterised by chronic sympathetic nervous system (SNS) overactivation and parasympathetic (vagal) withdrawal, resulting in elevated resting heart rate, reduced heart rate variability (HRV), and increased susceptibility to malignant arrhythmias. These autonomic perturbations are independently associated with excess mortality in CAD and heart failure. Exercise training within CR consistently restores autonomic balance: aerobic training reduces resting heart rate (a surrogate of improved vagal tone), increases HRV, and attenuates the exaggerated sympathetic response to physiological stressors. These autonomic adaptations reduce the arrhythmogenic substrate, lower myocardial oxygen demand at any given workload, and contribute to the observed reduction in sudden cardiac death associated with CR participation [5].
Endothelial Function and Vascular Adaptation
Endothelial dysfunction, characterised by reduced nitric oxide (NO) bioavailability, impaired vasodilatory capacity, and a pro-inflammatory, pro-thrombotic endothelial phenotype is a universal feature of established CVD and a critical mediator of atherosclerotic progression. Regular aerobic exercise within CR restores endothelial function through multiple mechanisms: increased shear stress stimulates endothelial nitric oxide synthase (eNOS) expression and activity, enhancing NO production; exercise reduces oxidative stress and scavenges reactive oxygen species that would otherwise inactivate NO; and regular exercise training upregulates antioxidant enzyme systems including superoxide dismutase and catalase. These vascular adaptations reduce arterial stiffness, lower central blood pressure, and attenuate the progression of atherosclerotic plaque, contributing to the long-term coronary risk reduction associated with CR [5,6].
Exercise Safety in Cardiac Populations
A common barrier to CR participation is patient and clinician concern regarding exercise safety. The evidence, however, consistently demonstrates that supervised CR exercise is extremely safe. A large registry study across 65 CR programmes reported one cardiac arrest per 116,906 patient-hours of exercise and one non-fatal event per 219,970 patient-hours, risks substantially lower than those associated with unsupervised recreational exercise in cardiac patients. Appropriate risk stratification, continuous ECG monitoring during Phase II, emergency preparedness protocols, and careful exercise progression are the safeguards that make CR exercise safe for patients spanning the full clinical risk spectrum. The exercise-related risk of serious adverse events in CR is consistently outweighed by the mortality benefit of programme participation [2].
Metabolic Health and Longevity Outcomes
The metabolic consequences of CVD and its major risk factors overlap profoundly with the metabolic features of accelerated biological aging. Insulin resistance, dyslipidaemia, central adiposity, chronic low-grade inflammation, mitochondrial dysfunction, and oxidative stress represent a shared pathophysiological terrain between cardiovascular disease and the aging process. Cardiac rehabilitation, through its integrated exercise, dietary, and behavioural components, addresses this terrain comprehensively.
Dyslipidemia Management
Dyslipidaemia, characterised by elevated LDL-C, triglycerides, and low HDL-C, is the most prevalent modifiable cardiovascular risk factor. While pharmacological lipid-lowering therapy (particularly statins and PCSK9 inhibitors) forms the cornerstone of medical management, CR produces independent, clinically meaningful improvements in the lipid profile beyond pharmacotherapy alone. Meta-analyses demonstrate that exercise-based CR produces reductions in total cholesterol (mean -0.37 mmol/L), LDL-C (mean -0.23 mmol/L), and triglycerides (mean -0.23 mmol/L), alongside increases in HDL-C (mean +0.04 mmol/L). The mechanisms include enhanced lipoprotein lipase activity (increasing triglyceride clearance), increased skeletal muscle VLDL uptake, and upregulation of hepatic LDL receptors. Nutritional counselling within CR, promoting Mediterranean-pattern dietary adherence, further amplifies these lipid-lowering effects [11].
Glucose Metabolism, Insulin Resistance, and Type 2 Diabetes
Type 2 diabetes mellitus affects approximately 30-40% of patients enrolled in CR programmes and confers a two- to three-fold greater risk of recurrent cardiovascular events compared to non-diabetic cardiac patients. Insulin resistance, the pathophysiological core of T2DM, is also an independent driver of atherosclerosis, endothelial dysfunction, and accelerated vascular aging. Exercise training within CR improves insulin sensitivity through multiple complementary mechanisms: (1) acute exercise stimulates insulin-independent GLUT-4 translocation to the skeletal muscle sarcolemma, increasing glucose uptake during and after exercise; (2) training-induced increases in skeletal muscle mass expand the primary site of glucose disposal; (3) increased mitochondrial oxidative capacity reduces intramyocellular lipid accumulation, a key molecular mediator of insulin resistance; (4) reductions in visceral adipose tissue decrease the secretion of pro-inflammatory, insulin-desensitising adipokines [6].
Clinical studies demonstrate that structured exercise interventions comparable to CR reduce HbA1c by 0.5-0.8% in T2DM patients, an effect comparable in magnitude to that of some second-line pharmacological agents including DPP-4 inhibitors. HOMA-IR (a surrogate measure of insulin resistance) improves significantly with CR participation, with greater benefits observed when resistance training is combined with aerobic exercise. These glycaemic improvements reduce microvascular and macrovascular complication risk and attenuate one of the most potent drivers of premature biological aging [9].
Body Composition and Visceral Adiposity
Central obesity and excess visceral adipose tissue (VAT) are central mediators of cardiometabolic risk. VAT is metabolically active, secreting a range of pro-inflammatory adipokines, including tumour necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), resistin, and leptin, while undersecreting the cardioprotective adipokine adiponectin. This adipokine dysregulation drives systemic insulin resistance, endothelial dysfunction, and a pro-atherogenic, pro-thrombotic state. CR exercise training, particularly when combined with caloric restriction guided by dietary counselling, reduces total body fat and VAT selectively, even in the absence of significant changes in total body weight. Dual-energy X-ray absorptiometry (DEXA) and computed tomography studies document meaningful reductions in VAT following CR, with corresponding improvements in adiponectin levels, insulin sensitivity, and inflammatory markers [5].
Systemic Inflammation and Inflammaging
Chronic low-grade systemic inflammation, characterised by persistent mild elevations of inflammatory cytokines including CRP, IL-6, and TNF-alpha is both a consequence of metabolic dysfunction and a driver of atherosclerotic progression, endothelial injury, plaque instability, and myocardial fibrosis. The concept of “inflammaging,” coined by Claudio Franceschi, describes the chronic, sterile, low-grade inflammatory state that accumulates with advancing age and accelerates the development of virtually all age-related diseases, including CVD . CR exercise training consistently reduces circulating hsCRP (typically by 20-40%), IL-6, and other inflammatory markers across multiple patient populations and study designs. The mechanisms are multifactorial: reductions in VAT decrease adipokine-driven inflammation; exercise-induced myokine secretion (particularly IL-10 and IL-1ra from contracting skeletal muscle) produces anti-inflammatory effects; and improvements in autonomic balance reduce SNS-driven immune activation. By attenuating inflammaging, CR interrupts a central driver of both cardiovascular disease progression and biological aging simultaneously [6,11,21].
Mitochondrial Function and Oxidative Metabolism
Mitochondrial dysfunction is a hallmark of both cardiovascular disease and biological aging. In the aging heart and skeletal muscle, mitochondrial density decreases, oxidative phosphorylation efficiency declines, and mitochondrial reactive oxygen species (ROS) production increase, a vicious cycle that impairs cellular energy metabolism, promotes oxidative damage, and accelerates cellular senescence. Aerobic exercise training potently stimulates mitochondrial biogenesis through the PGC-1alpha (peroxisome proliferator-activated receptor gamma coactivator-1 alpha) pathway, increasing mitochondrial density, respiratory chain complex activity, and oxidative capacity in skeletal muscle, adaptations that underlie a significant portion of the VO2max improvements observed with CR. In patients with heart failure, where mitochondrial dysfunction is particularly severe and contributes directly to exercise intolerance and poor prognosis, CR exercise training has been shown to partially restore mitochondrial function, representing a form of disease-modifying therapy at the organelle level [21].
Epigenetic Modifications and Biological Age
Epigenetic modifications, including DNA methylation, histone modification, and non-coding RNA regulation, regulate gene expression patterns associated with both cardiovascular function and the rate of biological aging. “Epigenetic clocks,” most prominently the Horvath and PhenoAge clocks based on DNA methylation patterns across hundreds of CpG sites, provide quantitative estimates of biological age that predict mortality, disease risk, and functional decline independently of chronological age. Emerging evidence from exercise biology research suggests that regular aerobic exercise is associated with slower epigenetic aging, reduced methylation age acceleration in both healthy adults and clinical populations. While CR-specific epigenetic aging data remain limited, the exercise dose delivered within CR programmes (and maintained thereafter) falls within the range documented to produce meaningful epigenetic effects. Longitudinal CR trials incorporating biological age assessment via epigenetic clocks represent a critical research priority for establishing CR as a bona fide anti-aging intervention [21].
Secondary Prevention and Cardiovascular Risk Reduction
The most mature and extensively documented evidence base for CR concerns its role in secondary prevention, the comprehensive reduction of cardiovascular risk and recurrent events in patients with established CVD. This evidence base, accumulated across more than four decades of RCTs, systematic reviews, and large-scale observational studies, constitutes the regulatory and guideline foundation for CR as a standard of care in post-MI, post-revascularisation, and heart failure populations.
Mortality Reduction: Trial Evidence
The definitive evidence for CR-associated mortality reduction derives from several systematic reviews and meta-analyses encompassing thousands of patients across multiple decades. The 2016 Cochrane systematic review and meta-analysis by Anderson et al., incorporating 63 RCTs and 14,486 participants, demonstrated that exercise-based CR reduced cardiovascular mortality by 26% (relative risk 0.74, 95% CI 0.64-0.86) and the risk of hospital readmission by 18% (RR 0.82, 95% CI 0.70-0.96) compared to usual care, without a statistically significant increase in adverse events. Earlier meta-analyses by Lawler et al. (2011) and Taylor et al. similarly documented significant reductions in mortality and recurrent MI, with effect sizes consistent across varying patient populations and follow-up durations [12,14].
Longer-term mortality data from observational studies extend these findings beyond the typical 12-24 month follow-up of most RCTs. Hammill et al. (2010), in a study of 601,099 Medicare beneficiaries following MI or CABG, demonstrated that attendance at more CR sessions was linearly associated with reduced five-year mortality: patients attending 36 sessions (the maximum reimbursed) had 14% lower mortality than those attending 24 sessions, who in turn had lower mortality than those attending fewer sessions, a dose-response relationship that strongly supports a causal interpretation of CR’s mortality benefit. A subsequent analysis by Goel et al. demonstrated that each additional CR session attended was associated with a stepwise mortality reduction, reinforcing the importance of programme completion [13].
Cardiac Rehabilitation in Heart Failure
Heart failure represents one of the fastest-growing cardiovascular diagnoses globally, affecting approximately 64 million people worldwide with a five-year mortality rate comparable to many cancers. Exercise intolerance, the hallmark symptom of HF, results from impaired cardiac output reserve, skeletal muscle atrophy, peripheral vascular dysfunction, and abnormal ventilatory responses. Historically, exercise was contraindicated in HF patients due to concerns about worsening ventricular function; this paradigm was overturned by the landmark HF-ACTION trial (O’Connor et al., 2009), which demonstrated that aerobic exercise training in HFrEF patients was safe and produced significant improvements in exercise capacity, HRQoL, and after adjustment for prespecified prognostic variables, significant reductions in all-cause mortality and hospitalisation. The Cochrane review by Taylor et al. (2014) confirmed these findings across 33 RCTs and 4,740 participants, establishing exercise-based CR as a Class I recommendation for stable HFrEF in current ESC guidelines [3,26].
Blood Pressure Control
Hypertension is present in more than 70% of patients enrolled in CR programmes and is the single most important modifiable risk factor for stroke and a major driver of heart failure progression. Exercise training within CR produces clinically meaningful reductions in resting blood pressure through multiple mechanisms: reduced SNS activity decreasing peripheral vascular resistance; improved endothelial function enhancing vascular compliance; reductions in body weight and visceral adiposity reducing renal sodium retention; and direct effects on the renin-angiotensin-aldosterone system (RAAS). Meta-analyses of exercise-based interventions in hypertensive patients document mean systolic blood pressure reductions of 4-9 mmHg and diastolic reductions of 3-5 mmHg with aerobic training, effects comparable to some antihypertensive medications and of sufficient magnitude to reduce stroke risk by approximately 14% and coronary event risk by approximately 9% at the population level [5].
Tobacco Cessation
Tobacco smoking is the most significant modifiable risk factor for initial CVD events and a powerful predictor of recurrent events and mortality in patients with established CVD. CR programmes incorporate structured smoking cessation support, combining pharmacotherapy (nicotine replacement therapy, varenicline, bupropion) with behavioural counselling and peer support within the therapeutic group context. The CR environment, characterised by regular supervised attendance, health professional interactions, and a shared commitment to cardiac health creates a particularly facilitative context for smoking cessation. Studies document smoking cessation rates of 30-50% among smokers who complete Phase II CR programmes, significantly exceeding cessation rates achieved through brief physician advice or pharmacotherapy alone. Each year of smoking cessation reduces excess cardiovascular mortality risk by approximately 50%, and within five years of cessation, risk approaches that of never-smokers underscoring the profound long-term benefit of CR-supported cessation [2].
Medication Adherence
Non-adherence to evidence-based cardiovascular pharmacotherapy (statins, antiplatelet agents, beta-blockers, ACE inhibitors/ARBs, and anticoagulants) is a major contributor to recurrent cardiovascular events and preventable death. CR programmes consistently improve medication adherence through patient education, motivational interviewing, pharmacist-led medication reviews, and the regular patient-healthcare professional contact inherent in Phase II attendance. Studies demonstrate that CR participants have significantly higher rates of statin adherence, antiplatelet use, and ACE inhibitor continuation compared to non-participants at 12 months post-event, improvements that translate directly to reduced event rates and downstream cost savings [2,15].
Health-Related Quality of Life
Beyond the hard endpoints of mortality and recurrent MI, CR consistently demonstrates robust improvements in health-related quality of life (HRQoL), an outcome of paramount importance to patients and increasingly to healthcare systems evaluating value-based care. Multiple validated instruments, including the Short Form-36 (SF-36), the MacNew Heart Disease Health-related Quality of Life Questionnaire, and the Minnesota Living with Heart Failure Questionnaire (MLHFQ), document improvements in physical functioning, role limitation, general health perception, vitality, social functioning, and mental health domains following CR. These HRQoL improvements reflect the convergent effects of improved fitness, better symptom control, reduced depression and anxiety, restored confidence in physical activity, and the psychosocial benefits of group-based rehabilitation [15].
Psychosocial Dimensions, Mental Health, and Lifestyle Integration
The psychosocial dimension of cardiac disease is as clinically significant as its physiological counterpart, yet it receives disproportionately less attention in routine cardiac care. The intersection of mental health, social functioning, and cardiovascular outcomes is bidirectional and complex: psychological distress worsens cardiovascular prognosis, while cardiac disease generates psychological distress. Cardiac rehabilitation, uniquely structured to address both physiological and psychosocial domains simultaneously, is one of the most powerful available treatments for this bidirectional relationship.
Prevalence and Impact of Depression and Anxiety in CVD
Depression affects approximately 20-30% of patients following acute MI, 25-45% of patients with chronic heart failure, and 35-45% of patients undergoing CABG surgery, rates two to three times higher than in age-matched community controls. Anxiety disorders, including generalised anxiety, panic disorder, and post-traumatic stress disorder (PTSD) triggered by the cardiac event itself, affect a further 25-40% of cardiac patients. These conditions are not merely comorbidities that coincidentally occur in cardiac populations; they are independent predictors of recurrent cardiac events and mortality. Depression following MI is associated with a two- to four-fold increased risk of recurrent MI and cardiovascular death, mediated through multiple pathways: heightened platelet reactivity, elevated cortisol and catecholamine levels, reduced HRV, impaired medication adherence, physical inactivity, and social isolation [16,17].
Cardiac Rehabilitation as a Mental Health Intervention
Cardiac rehabilitation is one of the most effective non-pharmacological interventions for depression and anxiety in cardiac populations, with an effect size comparable to or exceeding that of antidepressant pharmacotherapy in this specific context. A landmark prospective study by Milani and Lavie (2007) demonstrated that CR participation was associated with a 63% reduction in the prevalence of clinical depression, from 17% at programme entry to 6% at completion, compared to a 50% reduction with antidepressant medication in the same cohort [17]. The mechanisms underlying CR’s antidepressant effect are multifaceted: aerobic exercise stimulates neurobiological adaptations including increased brain-derived neurotrophic factor (BDNF) expression (promoting hippocampal neurogenesis and synaptic plasticity), enhanced serotonin and dopamine synthesis and release, reduced hypothalamic-pituitary-adrenal (HPA) axis reactivity, and normalisation of SNS hyperactivity. Beyond these neurobiological effects, the social interaction and sense of community provided by group-based CR, the restored self-efficacy from functional improvements, and the structured daily routine all contribute to improved psychological well-being [5].
Cognitive Function and Brain Health
Cognitive decline and dementia represent emerging frontiers in cardiovascular medicine and longevity science. CVD and its risk factors, particularly hypertension, diabetes, dyslipidaemia, obesity, and physical inactivity are major modifiable risk factors for both vascular dementia and Alzheimer’s disease, sharing common pathophysiological mechanisms including cerebral small vessel disease, neuroinflammation, reduced cerebral blood flow, and neurotrophic factor deficiency. Aerobic exercise, the core of CR, is the single most evidence-based lifestyle intervention for preserving cognitive function and reducing dementia risk across the adult lifespan. Exercise improves cerebral perfusion, stimulates BDNF-mediated neurogenesis, reduces cerebral amyloid burden in preclinical models, and improves executive function, working memory, and attention. While CR-specific cognitive outcome data are limited, the exercise dose of typical CR programmes (comparable to that used in dedicated cognitive exercise trials) is sufficient to produce meaningful cognitive benefits, particularly in the domains of executive function and psychomotor processing speed [5].
Sexual Function and Return to Normal Life Activities
Sexual dysfunction, including decreased libido, erectile dysfunction in men, and reduced sexual satisfaction in both sexes affects a substantial proportion of cardiac patients and is a source of significant psychological distress and relationship strain that is rarely addressed in routine cardiac care. Fear of triggering a cardiac event during sexual activity is common despite evidence that the cardiac energy expenditure of sexual activity (approximately 3-5 METs) is well within the capacity of most CR graduates. CR directly addresses this fear through structured patient education on sexual activity following cardiac events, using exercise capacity as an objective benchmark for readiness. Improved fitness, reduced anxiety, restored self-confidence, and the normative discussions of return to activity that occur within CR create an environment where sexual function concerns can be acknowledged and addressed contributing meaningfully to overall quality of life and relationship health.
Similarly, CR provides structured guidance on return to work, driving, recreational activities, and travel following a cardiac event, aspects of normal life that have profound implications for patients’ sense of identity, social functioning, and economic security. Occupational physiotherapists and cardiac nurses within the CR team are trained to provide individualised, evidence-based advice on these transitions, reducing the excessive activity restriction that leads to unnecessary disability and the self-imposed social withdrawal that reinforces depression and isolation.
Behavior Change Frameworks and Long-Term Adherence
Cardiac rehabilitation provides an exceptionally facilitative environment for health behaviour change, the sustained modification of lifestyle habits that is ultimately the primary determinant of long-term outcome. The “teachable moment” of a cardiac event creates heightened motivation and receptivity to behaviour change that, if harnessed effectively through CR, can translate into durable lifestyle modification. Contemporary CR programmes integrate evidence-based behaviour change frameworks including motivational interviewing, social cognitive theory (emphasising self-efficacy building and observational learning), the transtheoretical model of change (tailoring interventions to individual readiness), and cognitive-behavioural therapy (CBT) techniques for maladaptive health beliefs and avoidance behaviour. Group dynamics, a powerful but often underappreciated feature of Phase II CR, provides social modelling (observing peers successfully exercising and recovering), normative support (shared experience of cardiac recovery), and accountability that reinforces individual behaviour change [19].
Social Connectivity and Its Longevity Implications
Social isolation and loneliness have emerged as major independent risk factors for premature mortality, with a 2015 meta-analysis by Holt-Lunstad et al. demonstrating that social isolation was associated with a 29% increased mortality hazard (equivalent to smoking 15 cigarettes per day) and loneliness with a 26% increased risk. The mechanisms linking social isolation to mortality include immune dysregulation, elevated cortisol and sympathetic nervous system activity, sleep disruption, and reduced engagement with health-promoting behaviours. Cardiac patients, particularly those who are elderly, widowed, or living alone, are at high risk of social isolation following a cardiac event. The group-based structure of CR is inherently socially connective: participants form bonds with peers navigating similar challenges, interact regularly with a supportive healthcare team, and gain a sense of community and belonging that extends beyond the programme itself. These social benefits, while rarely quantified as a primary outcome in CR trials, may contribute substantially to the long-term mortality benefit of CR participation [20].
Cardiac Rehabilitation in Special Populations
A critical dimension of CR that is often overlooked in general reviews is its application to an evidence base within specific patient subgroups. Women, older adults, patients with heart failure with preserved ejection fraction (HFpEF), post-cardiac surgery patients, and individuals with concurrent metabolic syndrome represent distinct populations with unique needs, challenges, and patterns of benefit from CR.
Women and Cardiac Rehabilitation
Women are consistently underrepresented in both CR research and clinical practice, despite deriving equivalent or greater relative benefit from participation. Women are referred to CR less frequently than men following comparable cardiac events, enrol at lower rates when referred, and are more likely to drop out prematurely, a pattern of inequity well-documented across North America, Europe, and Australia. The barriers women face are multifactorial and include greater caregiving responsibilities (limiting availability for programme attendance), lower self-efficacy regarding exercise, higher rates of post-MI depression and anxiety (which reduce motivation), more atypical symptom presentations that are less frequently recognised as cardiac by both patients and providers, and cultural factors including modesty concerns in mixed-sex exercise settings [27].
Despite these barriers, women who complete CR demonstrate clinically significant improvements in CRF, HRQoL, depression, and cardiovascular risk factors, with relative mortality benefits equivalent to those seen in men. Programmes adapted to women’s specific needs, including female-only exercise sessions, greater integration of psychological support, flexible scheduling, and attention to gender-specific symptom presentations have demonstrated improved enrolment and completion rates. Addressing the CR gender gap is both an equity imperative and a public health priority [27].
Older Adults and Frailty
Older adults (typically defined as age 65 and above in CR literature, though the relevant biology begins earlier) represent the fastest-growing cardiac patient population and derive substantial, potentially disproportionate benefit from CR. Age-related reductions in CRF, muscle mass, balance, and functional reserve, the biological substrate of frailty, create a high-risk physiological phenotype in which a cardiac event can precipitate a rapid decline toward disability and dependence. CR exercise training in older patients consistently demonstrates significant improvements in VO2max, muscle strength, balance, and activities of daily living, outcomes that directly address frailty and its consequences [22].
Frailty assessment using validated tools (e.g., the Fried frailty phenotype, the Clinical Frailty Scale, or the SPPB) at CR entry enables individualised programme modification including lower initial exercise intensity, emphasis on functional movement patterns and balance training, closer supervision, and longer programme duration. The evidence supports that even frail older adults with multiple comorbidities can safely participate in appropriately modified CR and achieve meaningful functional gains. From a longevity perspective, the ability of CR to reverse pre-frailty and mild frailty in older cardiac patients represents one of its most clinically impactful and most underappreciated contributions.
Heart Failure with Preserved Ejection Fraction (HFpEF)
HFpEF , defined as symptomatic heart failure with a left ventricular ejection fraction of 50% or greater, is now the dominant heart failure phenotype, accounting for over half of all HF hospitalisations globally. Unlike HFrEF, HFpEF lacks disease-modifying pharmacological therapies proven to reduce mortality (with the recent exception of SGLT2 inhibitors), making lifestyle interventions including CR particularly important. HFpEF is characterised by exercise intolerance mediated by impaired cardiac reserve, systemic microvascular rarefaction, chronotropic incompetence, skeletal muscle dysfunction, and pulmonary hypertension, a multisystem phenotype requiring a multidomain therapeutic approach that CR is uniquely positioned to deliver. Emerging RCT evidence demonstrates that structured exercise training in HFpEF improves VO2peak, diastolic function, exercise tolerance, and HRQoL, supporting growing guideline endorsement of CR for this population [3].
Post-Cardiac Surgery Patients
Patients recovering from CABG, valve surgery, heart transplantation, or ventricular assist device (VAD) implantation face a distinct rehabilitation trajectory shaped by the physiological sequelae of cardiac surgery including sternal wound healing, pleural effusion, phrenic nerve injury, post-operative cognitive dysfunction, and post-operative depression. CR following cardiac surgery is associated with significant improvements in CRF, HRQoL, and return to work, with earlier Phase II initiation (within 2-3 weeks post-surgery, when sternal precautions allow appropriate exercise selection) associated with superior outcomes. Heart transplant recipients, who uniquely present with denervated hearts requiring adapted exercise protocols (relying on circulating catecholamines rather than cardiac neural reflexes for heart rate response) demonstrate remarkable CRF improvements with CR, often achieving levels of cardiorespiratory fitness comparable to healthy age-matched non-transplant controls with sustained training [9].
Cardiac Rehabilitation in the Context of Healthy Aging and Longevity Science
The Longevity Medicine Framework
Longevity medicine, as a clinical discipline, distinguishes between chronological age (time since birth) and biological age (the functional and molecular state of an organism relative to its chronological cohort). Biological age can be estimated using composite biomarker panels incorporating CRF, muscle mass and function, inflammatory markers, metabolic health parameters, epigenetic aging clocks, and telomere length. Interventions that reduce biological age relative to chronological age, extending the period of healthy function and compressing the period of pre-terminal morbidity, represent the central objective of longevity medicine. Cardiac rehabilitation, through its documented effects on CRF, metabolic health, inflammation, and increasingly via molecular aging biomarkers, is one of the most evidence-supported tools available for this objective.
VO2max as the Ultimate Longevity Biomarker
The most robust single predictor of longevity across diverse populations and clinical conditions is maximal aerobic capacity (VO2max). Data from the Cleveland Clinic cohort (Mandsager et al., 2018) demonstrated in 122,007 patients that low CRF carried a hazard ratio for all-cause mortality of 5.04 compared to elite CRF, a stronger association than any traditional cardiovascular risk factor, smoking, hypertension, diabetes, or dyslipidaemia. The survival benefit of moving from the lowest CRF quartile to the next achievable with regular aerobic training exceeded the benefit of any single pharmacological intervention in this cohort. Given that CR reliably increases VO2max by 10-25%, and that each 1 MET improvement in CRF is associated with approximately 13% lower all-cause mortality, the longevity calculus of CR participation is compelling across virtually all patient populations [10].
Hallmarks of aging: CR as a Multi-Target Intervention
Lopez-Otin et al. (2013) described the nine hallmarks of aging, universal biological processes that drive organismal senescence including genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. Regular aerobic exercise, as delivered within CR, demonstrably engages at least six of these hallmarks. Exercise attenuates telomere shortening by upregulating telomerase reverse transcriptase (TERT) activity in immune and vascular cells; activates SIRT1 and SIRT3 deacetylases that maintain epigenetic regulation and mitochondrial function; stimulates mitochondrial biogenesis via PGC-1alpha; activates autophagy, clearing misfolded proteins and damaged organelles (maintaining proteostasis); modulates AMPK and mTOR nutrient-sensing pathways, mimicking the caloric restriction response; reduces the senescence-associated secretory phenotype (SASP) that drives systemic inflammaging; and preserves muscle stem cell (satellite cell) function critical for skeletal muscle regeneration. No pharmacological agent has been demonstrated to favourably target as many hallmarks of aging simultaneously, underscoring the unique biological value of exercise as a systemic anti-aging intervention [21].
Telomere Biology and Exercise
Telomeres, the protective repetitive DNA sequences capping chromosome ends, shorten progressively with each cell division and with oxidative stress, representing a molecular clock of cellular aging. Short telomeres are associated with increased risk of CVD, metabolic disease, cancer, and all-cause mortality. Regular aerobic exercise has been associated with slower age-related telomere attrition in leukocytes and vascular cells across multiple observational studies and some interventional data, with the magnitude of benefit related to exercise intensity and duration. CR patients who maintain active lifestyles following programme completion represent a population in whom longitudinal telomere assessment could provide mechanistic insight into CR’s longevity biology, an important future research avenue.
Frailty Prevention as a Longevity Strategy
Frailty, defined as a state of increased vulnerability resulting from aging-associated decline in reserve and function across multiple physiological systems is strongly associated with adverse outcomes including falls, hospitalisation, disability, institutionalisation, and premature death. CVD is both a major contributor to frailty development and a frequent consequence of frailty progression. CR, by improving CRF, muscular strength, nutritional status, and psychosocial resilience simultaneously, addresses all five Fried criteria for frailty (weight loss, exhaustion, weakness, slowness, and physical inactivity) in a single intervention. The ability of CR to prevent frailty progression, reverse pre-frailty, and compress the morbidity associated with end-of-life cardiac decline represents one of its most clinically meaningful longevity contributions, yet remains underquantified in the CR outcome literature. Future trials incorporating frailty trajectories as primary endpoints would substantially strengthen this evidence base [22].
Barriers to Participation and Evidence-Based Strategies to Improve Uptake
The profound gap between the robust evidence for CR efficacy and the reality of its utilisation represents one of the most critical implementation failures in modern preventive medicine. Understanding and addressing this gap requires a systematic analysis of barriers operating at the patient, provider, programme, and system levels.
Patient-Level Barriers
Patient-level barriers to CR enrolment and completion are numerous and frequently intersecting. Lack of awareness remains primary: many patients are simply not informed by their healthcare providers that CR exists, that they are eligible, or that the evidence for benefit is compelling. Transportation difficulties, particularly for patients in rural areas, those without access to a personal vehicle, or those with physical limitations preventing independent driving, represent a practical barrier that has been consistently identified as a leading cause of non-enrolment. Competing work and family commitments, particularly relevant for working-age adults and primary caregivers, conflict with the fixed scheduling of traditional centre-based Phase II sessions. Comorbidities including musculoskeletal conditions, pulmonary disease, and frailty may require additional modifications that patients and caregivers are unaware CR can accommodate.
Psychological barriers are particularly significant and often overlooked. Depression, prevalent in 20-30% of cardiac patients reduces motivation, initiative, and self-efficacy, creating a self-reinforcing cycle in which those who would benefit most from CR’s antidepressant effects are least likely to engage. Fear of exercise triggering another cardiac event, despite the established safety of supervised CR, deters many patients, particularly following more severe events. Low health literacy impairs understanding of CR’s purpose and benefits. Cultural and linguistic barriers disproportionately affect minority and migrant populations who already face compounded cardiovascular risk. Socioeconomic barriers, including inability to afford programme costs or transportation, time lost from paid employment, and inadequate health insurance coverage, create access inequities that mirror the broader social determinants of health [4].
Provider and System-Level Barriers
Provider behaviour is a critical determinant of CR access: patients who receive a direct referral from their treating cardiologist or cardiac surgeon are substantially more likely to enrol in CR than those who are merely informed of its availability. Studies from multiple healthcare systems document that physician referral rates remain substantially below universal despite guideline recommendations, driven by competing clinical priorities, time constraints in consultations, perceived uncertainty about patient eligibility, and insufficient emphasis on CR in cardiology training programmes. Automatic referral systems, integrated within electronic health record platforms to generate a CR referral for every eligible discharge without requiring physician initiation have been demonstrated in multiple studies to increase enrolment rates by 30-50% relative to traditional physician-driven referral models [4].
System-level constraints including limited programme capacity, geographic maldistribution of CR centres (concentrated in urban tertiary hospitals), variable insurance reimbursement policies, and inconsistent integration of CR into post-discharge care pathways all contribute to the utilisation gap. In many low- and middle-income countries, structured CR programmes are essentially unavailable, restricting access to this evidence-based intervention to patients in higher-income settings. Addressing these systemic inequities requires policy-level investment in CR infrastructure, reimbursement reform, workforce development, and the strategic deployment of technology to extend programme reach.
Digital, Home-Based, and Hybrid Cardiac Rehabilitation
The COVID-19 pandemic, by necessitating the rapid closure of in-person CR programmes globally, catalysed the development, adaptation, and evaluation of home-based and digital CR (D-CR) at a pace that would otherwise have taken years. Remote CR delivery models, utilising smartphone applications, wearable biosensors, video consultation platforms, and telemonitoring systems to deliver structured exercise guidance, heart rate monitoring, psychosocial support, and patient education, have been evaluated in multiple RCTs with consistently encouraging results. A systematic review and meta-analysis by Rawstorn et al. (2016) demonstrated that telehealth exercise-based CR achieved comparable improvements in VO2max (mean difference -0.23 mL/kg/min in favour of centre-based, 95% CI -0.86 to 0.40, non-significant), exercise adherence, and secondary risk factor outcomes compared to traditional centre-based CR, while substantially reducing the transportation and scheduling barriers that limit access [19].
Contemporary D-CR platforms have evolved considerably beyond simple video consultations. Sophisticated wearable biosensor arrays now enable continuous real-time monitoring of heart rate, rhythm (including single-lead ECG for arrhythmia detection), oxygen saturation, activity levels, sleep quality, and even interstitial glucose providing the physiological safety data required to justify remote exercise supervision across a broad spectrum of cardiac risk profiles. AI-driven algorithms can analyse these biosensor data streams to dynamically adjust exercise intensity prescriptions, detect deviations from target heart rate zones, and alert clinicians to clinically significant physiological events. Patient-facing applications provide interactive exercise libraries, gamification elements that promote adherence, peer community forums, and educational modules that replicate the informational content of in-person CR [4,19].
Hybrid models, combining a reduced number of in-person supervised sessions (establishing the clinical relationship, performing comprehensive baseline assessment, and providing initial exercise instruction) with remotely monitored home-based exercise for the majority of training sessions, represent a pragmatic middle ground that preserves the irreplaceable benefits of direct clinical contact while substantially increasing scheduling flexibility and geographical reach. These models are increasingly endorsed by international CR professional bodies as complementary, rather than competing, approaches to traditional centre-based CR delivery.
Future Directions: Precision Cardiac Rehabilitation and the Longevity Frontier
Precision and Personalized Cardiac Rehabilitation
The next frontier of CR is precision medicine, the tailoring of every programme element (exercise prescription, nutritional intervention, pharmacological optimisation, and psychosocial support) to the individual patient’s unique biological, genetic, metabolic, and psychosocial profile. Current CR exercise prescription, while more individualised than most medical interventions, remains largely protocol-driven and population-average in its approach. Advances in multi-omic characterisation like genomics, metabolomics, proteomics, and epigenomics are beginning to identify molecular phenotypes that predict differential responses to specific exercise modalities, dietary patterns, and behavioural interventions. For example, genetic variants influencing skeletal muscle fibre type distribution, beta-adrenergic receptor sensitivity, and inflammatory cytokine production may predict which patients derive greater benefit from HIIT versus MICT, from higher versus lower volume resistance training, or from specific nutritional strategies. Integrating these molecular insights into CR programme design represents a realistic near-term objective, enabled by the declining cost of genomic analysis and the expanding infrastructure of electronic health records.
Artificial Intelligence, Machine Learning, and Wearable Technology
Artificial intelligence (AI) and machine learning (ML) are beginning to transform the operational landscape of CR in multiple domains. Predictive models trained on clinical, demographic, and behavioural data can identify patients at highest risk of CR non-enrolment, early dropout, or insufficient exercise engagement, enabling targeted proactive support before disengagement occurs. Natural language processing (NLP) algorithms applied to patient-reported outcomes and clinical notes may detect early signs of depression, anxiety, or motivational decline requiring intervention. Computer vision systems embedded in home-based CR platforms can assess exercise form and biomechanical safety during resistance training sessions, providing the kind of technique feedback previously available only in supervised settings. Reinforcement learning algorithms can dynamically adjust exercise intensity prescriptions in real time based on continuous biosensor data, a form of adaptive exercise prescription that accounts for day-to-day variability in physiological state that static protocols cannot address.
Advanced wearable technology is increasingly enabling the continuous, non-invasive monitoring of biomarkers previously measurable only in clinical laboratories. Continuous glucose monitors (CGMs) integrated into CR platforms allow real-time tracking of glycaemic responses to exercise, enabling personalised post-exercise nutritional guidance. Photoplethysmography (PPG)-based wearables can estimate blood pressure, oxygen saturation, and autonomic nervous system parameters continuously and unobtrusively. Implantable loop recorders and smartwatch ECG capabilities extend arrhythmia surveillance into the patient’s daily environment. These technological capabilities collectively create the possibility of a continuously monitored, adaptively managed CR experience that approaches the informational richness.
Integration with Longevity Medicine: A Vision for Comprehensive Health Span Programs
Perhaps the most transformative future direction for CR is its deliberate integration into comprehensive longevity medicine programmes. The emerging clinical discipline of longevity medicine, delivered through specialist longevity clinics, executive health programmes, and preventive medicine centres employs a battery of assessments including CPET, DEXA body composition, cognitive testing, biological age estimation (via epigenetic clocks, telomere length assays, and multi-analyte biomarker panels), metabolic profiling, and psychosocial evaluation to characterise the patient’s current biological age and trajectory, then deploys personalised interventions to slow or reverse biological aging. The exercise, nutritional, metabolic, and psychosocial components of CR map precisely onto the intervention toolkit of longevity medicine.
Conceptualising CR not as a disease-reactive intervention but as a proactive, evidence-based longevity programme, one that happens to be initiated by a cardiac event reframes its clinical purpose and broadens its potential reach. Under this framework, CR graduates who sustain their lifestyle modifications become participants in an ongoing longevity programme, with periodic biological age reassessment guiding adaptive intervention updates. Collaboration between cardiac rehabilitation specialists, longevity medicine physicians, geriatricians, endocrinologists, exercise scientists, nutritionists, and behavioural psychologists, all working within an integrated digital health infrastructure creates the conditions for a truly comprehensive, precision-personalised, longevity-oriented rehabilitation programme.
Research Priorities
Realising the longevity potential of CR requires a targeted research agenda. Priority areas include: (1) long-term RCTs (10+ years of follow-up) with biological age as a co-primary endpoint alongside traditional cardiovascular outcomes; (2) mechanistic studies incorporating epigenetic clock, telomere, and hallmark-of-aging assessments within CR cohorts; (3) pragmatic trials of hybrid and digital CR delivery in underserved populations including rural, low-income, and non-English-speaking communities; (4) precision CR trials stratifying exercise and nutritional prescriptions by genomic and metabolomic phenotype; (5) implementation science studies evaluating the effectiveness of automatic referral systems, nurse-led enrolment facilitation, and community health worker involvement in improving CR uptake in underserved populations; and (6) cost-effectiveness analyses of CR across diverse healthcare system contexts to inform reimbursement policy decisions at national and international levels.
Conclusion
Cardiac rehabilitation is far more than a post-acute care adjunct for survivors of myocardial infarction or cardiac surgery. It is a comprehensive, multidimensional therapeutic programme that simultaneously addresses every major physiological, metabolic, psychological, and behavioural determinant of cardiovascular health and biological aging. Through structured exercise training, it produces the most powerful single longevity intervention available in clinical medicine, improvements in cardiorespiratory fitness while simultaneously driving favourable metabolic reprogramming, attenuating inflammaging, preserving muscle mass, restoring autonomic balance, and improving endothelial function. Through its psychosocial and behavioural components, it reduces depression and anxiety, rebuilds self-efficacy, facilitates durable lifestyle change, and combats the social isolation that independently accelerates cardiovascular and all-cause mortality. Through its integrated risk factor management, it addresses the full spectrum of modifiable cardiovascular risk with a comprehensiveness and personalisation that routine outpatient care cannot replicate.
The evidence supporting CR across all these domains is not merely statistically significant, it is clinically transformative. A 26% reduction in cardiovascular mortality, 10-25% improvement in VO2max, 63% reduction in depression prevalence, and engagement of six hallmarks of biological aging represent outcomes that no single pharmacological agent approaches. And yet, CR is utilised by fewer than 30% of eligible patients globally, representing one of the most consequential evidence-to-practice gaps in contemporary medicine.
For clinicians working at the intersection of cardiovascular medicine, metabolic health, and longevity science, and for researchers, policymakers, and healthcare system leaders, the imperative is clear: cardiac rehabilitation must be reconceptualised, resourced, and championed as a cornerstone of longevity medicine. The integration of digital health platforms, artificial intelligence, wearable biosensors, and precision medicine frameworks provides the technological infrastructure to dramatically expand CR access while enhancing its personalisation and effectiveness. The biological and clinical evidence provides the scientific mandate. What remains is the collective clinical and political will to bridge the gap between what we know and what we deliver for the patients who have survived a cardiac event and deserve the fullest possible recovery, and for a population increasingly seeking not merely longer lives, but healthier, more vital ones.
Reference
1. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982-3021. doi:10.1016/j.jacc.2020.11.010
2. Balady GJ, Williams MA, Ades PA, Bittner V, Comoss P, Foody JM, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee. Circulation. 2007;115(20):2675-82. doi:10.1161/CIRCULATIONAHA.106.180945
3. Piepoli MF, Corra U, Benzer W, Bjarnason-Wehrens B, Dendale P, Gaita D, et al. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010;17(1):1-17. doi:10.1097/HJR.0b013e3283313592
4. Santiago de Araujo Pio C, Chaves GS, Davies P, Taylor RS, Grace SL. Interventions to promote patient utilisation of cardiac rehabilitation. Cochrane Database Syst Rev. 2019;2(2):CD007131. doi:10.1002/14651858.CD007131.pub4
5. Lavie CJ, Arena R, Swift DL, Johannsen NM, Sui X, Lee DC, et al. Exercise and the cardiovascular system: clinical science and cardiovascular outcomes. Circ Res. 2015;117(2):207-19. doi:10.1161/CIRCRESAHA.117.305205
6. Keteyian SJ, Brawner CA, Savage PD, Ehrman JK, Schairer J, Divine G, et al. Peak aerobic capacity predicts prognosis in patients with coronary heart disease. Am Heart J. 2008;156(2):292-300. doi:10.1016/j.ahj.2008.03.017
7. World Health Organization. Rehabilitation of Patients with Cardiovascular Disease: Report of a WHO Expert Committee. Technical Report Series No. 270. Geneva: WHO; 1964.
8. Pattyn N, Coeckelberghs E, Buys R, Cornelissen VA, Vanhees L. Aerobic interval training vs. moderate continuous training in coronary artery disease patients: a systematic review and meta-analysis. Sports Med. 2014;44(5):687-700. doi:10.1007/s40279-014-0158-x
9. Ades PA, Keteyian SJ, Balady GJ, Houston-Miller N, Kitzman DW, Mancini DM, et al. Cardiac rehabilitation exercise and self-care for chronic heart failure. JACC Heart Fail. 2013;1(6):540-7. doi:10.1016/j.jchf.2013.09.002
10. Martin BJ, Arena R, Haykowsky M, Hauer T, Austford LD, Knudtson M, et al. Cardiovascular fitness and mortality after contemporary cardiac rehabilitation. Mayo Clin Proc. 2013;88(5):455-63. doi:10.1016/j.mayocp.2013.02.013
11. Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med. 2005;143(9):659-72. doi:10.7326/0003-4819-143-9-200511010-00010
12. Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, et al. Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J Am Coll Cardiol. 2016;67(1):1-12. doi:10.1016/j.jacc.2015.10.044
13. Hammill BG, Curtis LH, Schulman KA, Whellan DJ. Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries. Circulation. 2010;121(1):63-70. doi:10.1161/CIRCULATIONAHA.109.876383
14. Lawler PR, Filion KB, Eisenberg MJ. Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J. 2011;162(4):571-584.e2. doi:10.1016/j.ahj.2011.07.017
15. Suaya JA, Shepard DS, Normand SL, Ades PA, Prottas J, Stason WB. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation. 2007;116(15):1653-62. doi:10.1161/CIRCULATIONAHA.107.701466
16. Blumenthal JA, Sherwood A, Babyak MA, Watkins LL, Waugh R, Georgiades A, et al. Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial. JAMA. 2005;293(13):1626-34. doi:10.1001/jama.293.13.1626
17. Milani RV, Lavie CJ. Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med. 2007;120(9):799-806. doi:10.1016/j.amjmed.2007.03.026
18. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the ENRICHD randomized trial. JAMA. 2003;289(23):3106-16. doi:10.1001/jama.289.23.3106
19. Rawstorn JC, Gant N, Direito A, Beckmann C, Maddison R. Telehealth exercise-based cardiac rehabilitation: a systematic review and meta-analysis. Heart. 2016;102(15):1183-92. doi:10.1136/heartjnl-2015-308966
20. Holt-Lunstad J, Smith TB, Baker M, Harris T, Stephenson D. Loneliness and social isolation as risk factors for mortality: a meta-analytic review. Perspect Psychol Sci. 2015;10(2):227-37. doi:10.1177/1745691614568352
21. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194-217. doi:10.1016/j.cell.2013.05.039
22. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics: 2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254-743. doi:10.1161/CIR.0000000000000950
23. Taylor RS, Sagar VA, Davies EJ, Briscoe S, Coats AJ, Dalal H, et al. Exercise-based rehabilitation for heart failure. Cochrane Database Syst Rev. 2014;(4):CD003331. doi:10.1002/14651858.CD003331.pub4
24. Mandsager K, Harb S, Cremer P, Phelan D, Nissen SE, Jaber W. Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing. JAMA Netw Open. 2018;1(6):e183605. doi:10.1001/jamanetworkopen.2018.3605
25. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793-801. doi:10.1056/NEJMoa011858
26. O’Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301(14):1439-50. doi:10.1001/jama.2009.454
27. Grace SL, Midence L, Oh P, Brister S, Stewart DE, Chessex C. Cardiac rehabilitation program adherence and functional capacity among women: a randomized controlled trial. Mayo Clin Proc. 2016;91(2):140-8. doi:10.1016/j.mayocp.2015.10.021
28. Heran BS, Chen JM, Ebrahim S, Moxham T, Oldridge N, Rees K, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2011;(7):CD001800. doi:10.1002/14651858.CD001800.pub2
29. Conn VS, Hafdahl AR, Moore SM, Nielsen PJ, Brown LM. Meta-analysis of interventions to increase physical activity among cardiac subjects. Int J Cardiol. 2009;133(3):307-20. doi:10.1016/j.ijcard.2008.01.010
30. Franklin BA, Lavie CJ, Squires RW, Milani RV. Exercise-based cardiac rehabilitation and improvements in cardiorespiratory fitness: implications regarding patient benefit. Mayo Clin Proc. 2013;88(5):431-7. doi:10.1016/j.mayocp.2013.03.009
31. Ekelund U, Steene-Johannessen J, Brown WJ, Fagerland MW, Owen N, Powell KE, et al. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. Lancet. 2016;388(10051):1302-10. doi:10.1016/S0140-6736(16)30370-1
32. International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: IDF; 2021. Available from: https://www.diabetesatlas.org